BETA

IPO registrations (S-1, F-1) · Registrants

ELITE PHARMACEUTICALS INC /NV/

SEC CIK
1053369 · filings on EDGAR ↗
Former names
ELITE PHARMACEUTICALS INC /DE/ (1998–2012)
Registration
Form S-1, first filed 2005-04-27, last 2016-06-27; 4 initial registrations, 2 amendments
Outcome
Final prospectus filed 2006-04-26; declared effective 2007-07-10; withdrawal requested 2006-03-01
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
NJ
Business address
165 LUDLOW AVENUE, Northvale, NJ 07647
EIN
22-3542636
Ticker
ELTP (OTC)
EDGAR entity type
operating
Insiders and CEO pay
ELITE PHARMACEUTICALS INC /NV/ on the corporate pages

Offering terms

Shares offered
2,402,181
Listing
NYSE American under the symbol ELI

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 20

FiledFormWhat it isName as filedEDGAR
2005-04-27S-1S-1 (registration)ELITE PHARMACEUTICALS INC /DE/0000930413-05-003067 ↗
2006-03-01RWRW (withdrawal request)ELITE PHARMACEUTICALS INC /DE/0000930413-06-001632 ↗
2006-03-01RWRW (withdrawal request)ELITE PHARMACEUTICALS INC /DE/0000930413-06-001638 ↗
2006-04-26424B1424B1 (final prospectus)ELITE PHARMACEUTICALS INC /DE/0000930413-06-003182 ↗
2006-04-26424B1424B1 (final prospectus)ELITE PHARMACEUTICALS INC /DE/0000930413-06-003186 ↗
2007-07-10EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /DE/9999999995-07-002751 ↗
2007-07-10EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /DE/9999999995-07-002753 ↗
2008-01-25EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /DE/9999999995-08-000281 ↗
2012-03-01S-1S-1 (registration)ELITE PHARMACEUTICALS INC /NV/0001144204-12-012352 ↗
2012-06-20RWRW (withdrawal request)ELITE PHARMACEUTICALS INC /NV/0001144204-12-035554 ↗
2013-04-25S-1S-1 (registration)ELITE PHARMACEUTICALS INC /NV/0001144204-13-024005 ↗
2013-05-09EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /NV/9999999995-13-001470 ↗
2013-06-27EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /NV/9999999995-13-001936 ↗
2014-04-28S-1/AS-1/A (amendment)ELITE PHARMACEUTICALS INC /NV/0001144204-14-025309 ↗
2014-05-01S-1/AS-1/A (amendment)ELITE PHARMACEUTICALS INC /NV/0001144204-14-026890 ↗
2014-05-01EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /NV/9999999995-14-001293 ↗
2014-07-08EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /NV/9999999995-14-002079 ↗
2016-06-27S-1S-1 (registration)ELITE PHARMACEUTICALS INC /NV/0001144204-16-110012 ↗
2016-07-13EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /NV/9999999995-16-005138 ↗
2017-06-05EFFECTEFFECT (declared effective)ELITE PHARMACEUTICALS INC /NV/9999999995-17-001452 ↗

Prospectus pages read 3

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2005-04-27S-1registration statement2,402,181-NYSE American ELI0primary document; shares headlinedocument ↗
2006-04-26424B1final prospectus--NYSE American ELI0primary document; no terms founddocument ↗
2006-04-26424B1final prospectus7,298,245-NYSE American ELI0primary document; shares headlinedocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BEHL CHARANOfficer; OtherExec V.P. & Chief Sci Officer; Exec VP & Chief Sci. Officer152006–2008
DICK CHRISDirector,Officer; OfficerExecutive VP of Corporate Dev.; Exec. VP of Corp. Development; President & COO72006–2013
NEUGEBOREN EDWARDDirector12006
Gittelman MarkOfficerChief Financial Officer12006
BERK BERNARDDirector,OfficerCEO and Chairman; Chairman, CEO and President32006–2008
Subramanian VeerappanDirector12006
Dash Barry HDirector172007–2026
LEVENSON ROBERT JDirector22007–2008
APFEL STUART CHARLESOfficerChief Medical Officer12008
Van Woert Melvin HDirector12008
TREPPEL JERRYDirector; Director,Officer; OtherChairman & CEO; Chairman & (CEO as of filing); Chairman of Board; Chairman of the Board212008–2016
Trellus Management Company, LLCTenPercentOwner402009–2011
Trellus Offshore Fund LtdTenPercentOwner402009–2011
TRELLUS PARTNERS LPTenPercentOwner362009–2011
Usdan AdamDirector; TenPercentOwner402009–2011
EPIC INVESTMENTS, LLCTenPercentOwner382009–2015
EPIC PHARMA LLCTenPercentOwner422009–2015
NARINE JEENARINEDirector; Director,TenPercentOwner; Other542009–2016
NIGALAYE ASHOK GDirector; Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwnerChief Financial Officer; Chief Scientific Officer; Scief Scientific Officer552009–2015
POTTI RAMDirector,TenPercentOwner; TenPercentOwner302009–2015
Ward Carter JulianDirector; Director,Officer; Officer; OfficerOtherCFO, Secretary, Treasurer; CFO, Sec., Treas; CFO, Sec., Treas.; Chief Financial Officer; Chief Financial Officer & Sec.; Chief Financial Officer, Sec.162009–2018
TRELLUS PARTNERS II LPTenPercentOwner212010–2011
WHITNELL JEFFREY ADirector132011–2023
Hakim Nasrat ADirector,Officer; Director,Officer,TenPercentOwnerCEO & President; CEO, President; Chairman, CEO, President; President & CEO182013–2024
Plassche DouglasOfficer; TenPercentOwnerEVP Operations; Executive VP of Operations; Executive VP Operations; Exec Vice Pres Operations; Senior VP of Operations; SVP of Operations; SVP Operations152015–2026
Mikah Pharma, LLCTenPercentOwner12016
Pfeifer Eugene MDirector32016–2018
Caskey Davis SDirector72016–2023
Bregman MarcOfficerCFO, Secretary, Treasurer22021
Chen Robert C JOfficerCFO, Secretary, Treasurer22022
Kirkov KirkoOfficerChief Commercial Officer32022–2025
Pellegrino Mark NOfficerCFO, Secretary, Treasurer12023
ELITE PHARMACEUTICALS INC /NV/OfficerEVP Operations12025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2020-07-13ELITE PHARMACEUTICALS INC /NV/Pharmaceuticals$26,000,000$500,00011
2017-05-10ELITE PHARMACEUTICALS INC /NV/Pharmaceuticals$41,600,000$800,00011
2014-04-15ELITE PHARMACEUTICALS INC /NV/Pharmaceuticals$41,600,000$800,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerELITE PHARMACEUTICALS INC /NV/NJForm D private offeringsCIK (EXACT)
SEC filerELITE PHARMACEUTICALS INC /NV/SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NJ first:

More with this interest.

In other datasets, the same topic (Health) in NJ:

Interests: Pharmaceutical Preparations · Health